In this episode of Vpod.ai, we explore a groundbreaking collaboration between the World Health Organization, Medicines Patent Pool, SD Biosensor, and Codex Bio, a leading African health tech company. Discover how a new technology transfer agreement is enabling local production of rapid diagnostic tests (RDTs) for HIV and beyond — and why this could be a turning point for global health equity.We break down:<ul><li>What the HTAP (Health Technology Access Pool) initiative is and how it evolved from the COVID-19 pandemic</li><li>The significance of local manufacturing for diagnostics in low- and middle-income countries</li><li>How this model improves pandemic preparedness, strengthens health sovereignty, and empowers regional healthcare systems</li><li>The broader implications for malaria, syphilis, and emerging disease detection</li></ul>👉 Tune in to see how this strategic cooperation might redefine how we fight future health crises — not just in Africa, but globally.

How Local Diagnostic Manufacturing Is Transforming Global Health Access